Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
 

Investors

+

Main navigation

Main navigation

  • News - Press releases
  • Financial Calendar
  • Financial reports
  • Corporate governance
    • Articles Of Association
    • AGM and Extraordinary general meetings
      • ANNUAL GENERAL MEETING MAY 28TH 2025
      • Extraordinary general meeting 21 March 2025
      • Extraordinary general meeting Nov 8th 2024
      • ANNUAL GENERAL MEETING JUNE 26TH 2024
      • Extraordinary general meeting 23 April 2024
      • EXTRAORDINARY GENERAL MEETING 16 JANUARY 2024
      • Annual General Meeting May 4th 2023
      • EXTRAORDINARY GENERAL MEETING 24 MARCH 2023
      • EXTRAORDINARY GENERAL MEETING 27 SEPTEMBER 2022
      • Annual General Meeting on May 5 2022
      • Annual general meeting on 5 May 2021
      • Extraordinary Shareholders Meeting 19 November 2020
      • Extraordinary general meeting January 2020
      • Annual General Meeting, May 20, 2020
    • Auditor
    • Certified adviser
  • Share information
    • Sharecapital
    • Incentive programme
    • Dividend Policy
    • Rights issue 2022
    • Rights issue 2023
    • Rights issue 2024
    • RIGHTS ISSUE 2025
    • Warrants (TO)
    • IPO and listning documents
  • Board
  • Management
  • Insiders
  • Analyst
  • IR Contact
  • Presentations

Board

Flemming Pedersen

Chairman since 2025 

Flemming is CFO and Executive Vice President of Better Collective, a digital media group listed on Nasdaq Stockholm and Nasdaq Copenhagen, Flemming brings extensive leadership experience. With over 20 years in the pharmaceutical industry and a track record of executive roles in publicly traded companies, he adds valuable strategic and financial expertise to Qlife.

Jacob Glenting

Board member since 2025 

Jacob is a pharmaceutical commercialization expert with extensive experience in R&D, M&A, strategic partnerships, and market expansion. He is currently a member of ALK Abelló's executive leadership team, where he leads the “Global Strategy and Corporate Development”, bringing valuable strategic and business development expertise to Qlife.

Jørgen Drejer

Board member since 2025 

Jørgen sas dedicated his entire career to the pharmaceutical industry, founding or co-founding several biotech companies including Saniona AB and NeuroSearch A/S, where he also served as Chief Scientific Officer. With extensive board experience and business network, he is bringing deep scientific and strategic expertise to Qlife.

Lars Staal Wegner

Lars Staal Wegner

Board member since 2023

Lars Staal Wegner is a physician with over 20 years of experience in the biotechnology and technology sectors. Lars has previously served as CEO of Evaxion Biotech, an AI biotechnology company listed on the American Nasdaq. Lars has built several companies in the biotechnology and technology industries and is active on multiple boards. He is currently a founding partner at the venture fund, Bristlecone Pacific Ventures, which invests in the preventive health ecosystem.

 

Mikael Persson

Board member since 2021

Mikael Persson has eight years of global experience in the medtech industry in senior positions within Supply Chain and product development, and is currently the Chief Supply Chain Officer at Stokke. Mikael has participated in and led several major product developments in collaboration with third parties globally and has previous experience in various positions at Alfa Laval, including as VP Operations - Operations Development Manager, Supply Chain Director for Cardo Flow Solutions and Flûgger A/S, VP Supply Chain ArjoHuntleigh AB, and COO Manufacturing Capital Equipment for Getinge. Mikael holds a master's degree in mechanical engineering from Lund University.
 

Qlife

Qlife Holding AB
Nellickevägen 22
SE-412 63 Göteborg
info@egoo.health
Last published: 2025-02-10

Links

  • About
  • Investors
  • Egoo.health

Qlife is born to challenge the status quo in healthcare. We work to shift the perspective and turn today's view on health-care into tomorrow's focus on health-empowerment. We are on a quest to empower people with more accessible ways to understand their health - so that they can move beyond reactive care towards proactive wellbeing. it's how we contribute to improving quality of life for every individual and for the greater society.